Press Releases & Announcements

STUDY A5349 PUBLISHED IN NEJM

Jun 07, 2021

CENTRAL MONITORING IN A RANDOMIZED, OPEN-LABEL, CONTROLLED PHASE 3 CLINICAL TRIAL FOR A TREATMENT-SHORTENING REGIMEN FOR PULMONARY TUBERCULOSIS

May 01, 2021

ACTG LEADERSHIP STATEMENT ON DEREK CHAUVIN VERDICT

Apr 22, 2021

ACTG ADDS FIRST POLYCLONAL ANTIBODY TO ACTIV-2 OUTPATIENT TREATMENT STUDY FOR COVID-19

Apr 21, 2021

JOHN. G. GERBER, MD

Mar 04, 2021

ACTG TO PRESENT 24 NEW STUDIES AT CROI 2021

Mar 03, 2021

ACTG ADDS FOUR PROMISING NEW THERAPIES TO ACTIV-2 OUTPATIENT TREATMENT STUDY

Feb 12, 2021

JOHN G. BARTLETT, MD

Feb 02, 2021

PROFESSOR JAMES G. HAKIM

Feb 02, 2021

DAVID KATZENSTEIN, MD

Feb 02, 2021

FRANCES CANCHOLA

Feb 02, 2021

NED SACKTOR, MD

Feb 02, 2021